valerates has been researched along with Cardiovascular Stroke in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baggs, GE; Deutz, NE; Luo, M; Matheson, EM; Nelson, JL | 1 |
| Baggs, GE; Deutz, NE; Hegazi, RA; Luo, M; Matarese, LE; Matheson, EM; Nelson, JL; Tappenden, KA; Ziegler, TR | 1 |
| Eisalo, A; Kuusisto, P; Mälkönen, M; Manninen, V; Tuomilehto, J; Virtamo, J | 1 |
| Elo, MO; Frick, MH; Haapa, K; Heinonen, OP; Heinsalmi, P; Helo, P; Huttunen, JK; Kaitaniemi, P; Koskinen, P; Manninen, V | 1 |
4 trial(s) available for valerates and Cardiovascular Stroke
| Article | Year |
|---|---|
Specialized oral nutritional supplement (ONS) improves handgrip strength in hospitalized, malnourished older patients with cardiovascular and pulmonary disease: A randomized clinical trial.
Topics: Activities of Daily Living; Aftercare; Aged; Dietary Proteins; Dietary Supplements; Double-Blind Method; Energy Intake; Female; Hand Strength; Heart Failure; Hospitalization; Humans; Male; Malnutrition; Myocardial Infarction; Nutritional Status; Patient Discharge; Pneumonia; Pulmonary Disease, Chronic Obstructive; Valerates | 2021 |
Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial.
Topics: Activities of Daily Living; Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Body Weight; Dietary Proteins; Dietary Supplements; Double-Blind Method; Endpoint Determination; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Male; Malnutrition; Myocardial Infarction; Nutritional Status; Patient Readmission; Pneumonia; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Valerates | 2016 |
Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clinical Trials as Topic; Follow-Up Studies; Gemfibrozil; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Myocardial Infarction; Pentanoic Acids; Valerates | 1982 |
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
Topics: Adult; Coronary Disease; Double-Blind Method; Finland; Gemfibrozil; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Myocardial Infarction; Pentanoic Acids; Random Allocation; Risk Factors; Valerates | 1988 |